Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
18765 | 471 | 25.6 | 67% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2030 | 4913 | CARDIOPULMONARY BYPASS//APROTININ//PERFUSION-UK |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HEPARIN RESISTANCE | Author keyword | 10 | 50% | 3% | 14 |
2 | ACTIVATED CLOTTING TIME | Author keyword | 9 | 30% | 5% | 25 |
3 | ACTIVATED COAGULATION TIME | Author keyword | 8 | 50% | 3% | 12 |
4 | ACTIVATED CLOTTING TIME ACT | Author keyword | 3 | 60% | 1% | 3 |
5 | HEPARIN REBOUND | Author keyword | 3 | 60% | 1% | 3 |
6 | ALLEN FORMULA | Author keyword | 1 | 100% | 0% | 2 |
7 | BLOOD HEPARIN CONCENTRATION | Author keyword | 1 | 100% | 0% | 2 |
8 | CARDIAC CATHETERIZAT L2 | Address | 1 | 50% | 0% | 2 |
9 | HEPARIN MANAGEMENT TEST HMT | Author keyword | 1 | 100% | 0% | 2 |
10 | MAIN OPERATING THEAT | Address | 1 | 50% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ACTIVATED CLOTTING TIME | 27 | 32% | 15% | 70 |
2 | COAGULATION TIME | 26 | 56% | 7% | 32 |
3 | HEPARIN RESISTANCE | 17 | 72% | 3% | 13 |
4 | SUBCLINICAL PLASMA COAGULATION | 15 | 88% | 1% | 7 |
5 | HEPARIN CONCENTRATION | 11 | 67% | 2% | 10 |
6 | HEMOSTATIC ACTIVATION | 7 | 48% | 2% | 11 |
7 | CLOTTING TIME | 7 | 25% | 5% | 24 |
8 | ACTIVATED COAGULATION TIME | 6 | 45% | 2% | 10 |
9 | DOSE THROMBIN TIME | 6 | 100% | 1% | 4 |
10 | RECOMBINANT HUMAN ANTITHROMBIN | 5 | 32% | 3% | 13 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Heparin Sensitivity and Resistance: Management During Cardiopulmonary Bypass | 2013 | 10 | 135 | 50% |
Treating heparin resistance with antithrombin or fresh frozen plasma | 2008 | 26 | 42 | 55% |
Anticoagulation monitoring during cardiac surgery - A review of current and emerging techniques | 1999 | 125 | 250 | 21% |
Blood loss after cardiopulmonary bypass, standard vs titrated protamine: A meta-analysis | 2013 | 1 | 15 | 53% |
Heparin Resistance and Antithrombin Deficiency | 2009 | 6 | 65 | 43% |
Monitoring of heparin therapy during extracorporeal bypass: what are the remaining questions? | 2004 | 4 | 42 | 62% |
THE USE OF ACTIVATED CLOTTING TIMES TO MONITOR HEPARIN-THERAPY DURING AND AFTER INTERVENTIONAL PROCEDURES | 1994 | 34 | 20 | 75% |
Heparin resistance and the potential impact on maintenance of therapeutic coagulation | 2007 | 2 | 156 | 36% |
Recombinant antithrombin: Production and role in cardiovascular disorder | 2001 | 14 | 91 | 29% |
ACTIVATED CLOTTING TIME VERSUS ACTIVATED PARTIAL THROMBOPLASTIN TIME FOR THERAPEUTIC MONITORING OF HEPARIN | 1995 | 22 | 27 | 33% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CARDIAC CATHETERIZAT L2 | 1 | 50% | 0.4% | 2 |
2 | MAIN OPERATING THEAT | 1 | 50% | 0.4% | 2 |
3 | CARDIAC PERFUS | 1 | 25% | 0.6% | 3 |
4 | CARDIOTHORAC ANESTHESIOL CRIT CARE | 1 | 15% | 1.1% | 5 |
5 | AFFILIATED HOSP XINJIANG 1 | 1 | 50% | 0.2% | 1 |
6 | EP617 | 1 | 50% | 0.2% | 1 |
7 | HEMATOL BIOL HEMOBIOL TRANSFUS | 1 | 50% | 0.2% | 1 |
8 | HEMOSTASIS GRP | 1 | 50% | 0.2% | 1 |
9 | INTERNAL MED IDENT PGY3 | 1 | 50% | 0.2% | 1 |
10 | POLICLIN S DONATOL | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000295248 | APROTININ//TRANEXAMIC ACID//EPSILON AMINOCAPROIC ACID |
2 | 0.0000292449 | PROTAMINE//PROTAMINE TOXICITY//PROTAMINE IMMOBILIZATION |
3 | 0.0000224753 | HEPARIN SOLUTION//NORMAL SALINE FLUSH//ARTERIAL LINES |
4 | 0.0000155235 | COLLOIDAL TITRATION//FLOW THROUGH ION SENSOR//POLYION SENSITIVE ELECTRODE |
5 | 0.0000137207 | LOW MOLECULAR WEIGHT HEPARIN//UNFRACTIONATED HEPARIN//ANTI XA ACTIVITY |
6 | 0.0000110828 | EPTIFIBATIDE//TIROFIBAN//ABCIXIMAB |
7 | 0.0000095346 | MASSIVE TRANSFUSION//THROMBOELASTOMETRY//THROMBOELASTOGRAPHY |
8 | 0.0000090364 | HEPARIN COFACTOR II//ANTITHROMBIN//ANTITHROMBIN DEFICIENCY |
9 | 0.0000089383 | CARDIOPULMONARY BYPASS//PERFUSION-UK//MODIFIED ULTRAFILTRATION |
10 | 0.0000087055 | TRANSRADIAL APPROACH//TRANSRADIAL//BIVALIRUDIN |